VolkowND: Stigma and the toll of addiction. N Engl J Med, 2020; 382:1289–1290.
2.
WoodsJS, JosephH: Stigma from the viewpoint of the patient. J Addict Dis, 2015; 34:238–247.
3.
EbenauA, DijkstraB, ter HuurneC, et al.: Palliative care for patients with substance use disorder and multiple problems: A qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience. BMC Palliat Care, 2020; 19:8.
4.
McCraddenMD, VasilevaD, Orchanian-CheffA, BuchmanDZ: Ambiguous identities of drugs and people: A scoping review of opioid-related stigma. Int J Drug Policy, 2019; 74:205–215.
5.
P. Goddu A, O'Conor KJ, Lanzkron S, et al.: Do words matter? Stigmatizing language and the transmission of bias in the medical record. J Gen Intern Med, 2018; 33:685–691.
6.
WakemanSE: Language and addiction: Choosing words wisely. Am J Public Health, 2013; 103:e1–e2.
7.
LinkBG, PhelanJC: Conceptualizing stigma. Annu Rev Sociol, 2001; 27:363–385.
8.
CourtwrightDT: Preventing and treating narcotic addiction—Century of Federal Drug Control. N Engl J Med, 2015; 373:2095–2097.
9.
AdamsVJM, VolkowND: Ethical imperatives to overcome stigma against people with substance use disorders. AMA J Ethics, 2020; 22:702–708.
10.
van BoekelLC, BrouwersEPM, van WeeghelJ, GarretsenHFL: Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug Alcohol Depend, 2013; 131:23–35.
AveryJ, KnoepflmacherD, MauerE, et al.: Improvement in residents' attitudes toward individuals with substance use disorders following an online training module on stigma. HSS J, 2019; 15:31–36.
13.
KellyJF, DowSJ, WesterhoffC: Does our choice of substance-related terms influence perceptions of treatment need? An empirical investigation with two commonly used terms. J Drug Issues, 2010; 40:805–818.
14.
BearnotB, MittonJA, HaydenM, ParkER: Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study. J Subst Abuse Treat, 2019; 102:16–22.
15.
SimonR, SnowR, WakemanS: Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus, 2020; 41:519–525.
16.
WakemanSE, RichJD: Barriers to medications for addiction treatment: How stigma kills. Subst Use Misuse, 2018; 53:330–333.
WakemanSE, LarochelleMR, AmeliO, et al.: Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open, 2020; 3:e1920622–e1920622.
19.
TsaiAC, KiangMV, BarnettML, et al.: Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Med, 2019; 16:e1002969.
20.
KellyJF, WakemanSE, SaitzR: Stop Talking ‘Dirty’: Clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med, 2015; 128:8–9.
21.
BotticelliMP, KohHK: Changing the language of addiction. JAMA, 2016; 316:1361–1362.
22.
AlfandreD, BrennerJ, OnukwughaE: Things we do for no reason: Against medical advice discharges. J Hosp Med, 2017; 12:843–845.
23.
BellK, SalmonA: Pain, physical dependence and pseudoaddiction: Redefining addiction for ‘nice’ people?. Int J Drug Policy, 2009; 20:170–178.